November 19, 2020 November 19, 2020Ampersand Announced Today the $670 Million Closing of the Ampersand Continuation Fund (“AMP-CF”) with Confluent Medical Technologies as Core Asset
November 11, 2020 November 11, 2020With new CEO on board, Germany’s Vibalogics lays out $150M for Boston viral vector site
October 21, 2020 October 21, 2020StageBio Expands Its Global Presence With Acquisition of TPL Path Labs
October 2, 2020 October 2, 2020CEPI establishes global network of laboratories to centralise assessment of COVID-19 vaccine candidates
September 21, 2020 September 21, 2020GeneWerk GmbH Announces Growth Equity Investment from Ampersand Capital Partners
September 21, 2020 September 21, 2020Ampersand Capital Partners Acquires American Laboratory Products Company
